Post by Geisinger

Precision medicine is no longer a future concept — it’s a present-day imperative. Geisinger’s MyCode® Community Health Initiative has played a key role in integrating genomics into routine care — supporting a future where precision medicine becomes standard, not specialized. With more than 370,000 participants and one of the largest health system–linked biobanks in the world, this work highlights the impact of embedding genomic insights across specialties — from oncology to cardiology and beyond. While progress is strong, challenges such as reimbursement, data integration and adoption remain. “There’s a lot of movement in those areas, but there still needs to be a lot of coordination,” says Dr. Christa Lese Martin, chief scientific officer at Geisinger. 🔗 Read the full article here: https://lnkd.in/e4P3DwrG